I Had this Cool Idea
A New Report: 5 Speculative (and Cheap) Doublers
Dear Bottarelli Research Member,
Earlier this week, I pointed out a cheap upside call option on Merck (MRK – NYSE). It was two days ago, on July 26th, where I wrote that the MRK January 45 Calls (MRK AI) could be a nice speculative play for only $0.45 per contract. I calculated that if Merck moved up just $2.50 over the next six months, you could have a straight double on these calls – which made it a speculation worth taking.
Although it wasn’t an official recommendation, I’ve been following this position over the last few days. And right now, the MRK January 45 Calls (MRK AI) are now trading for $1.05. That’s a 133% gain in just two days! (Note: If you did make this play, take your profits!)

Based on this move, I had an idea for a new special report. I’d like to isolate a handful of stocks in strong 6-month up-trends or strong 6-month down-trends, and use this prevailing trend to discover cheap, out-of-the-money calls (or puts) that carry into January of 2007. If I can find, for example, five $0.45 options like I did for Merck, you can pay a total of $2.25 to own all five positions. And if these stocks continue to move as suggested by their established trend-lines, I think all five could eventually double!
I would call the report something like “5 Speculative (and Cheap) Doublers” and I’d make the recommendations good over the longer-term, similar to what I did with the picks from the “Aftermath Report.” Given how this latest Merck play performed, I think this could be a valuable addition to our daily trades.
Next week, I plan to begin my due diligence on this special report. And unlike other newsletter services, which aim to charge hundreds of dollars for this type of research, I will be giving this report to you — free of charge. In my book, it’s already included in the total benefit package of being a Charter Member to BottarelliResearch. So stay tuned for this new report — which could probably be available towards the end of August. As you can probably tell, the sweet taste of the Merck play has gotten my interest, so I’ll look to uncover similar opportunities like this for you moving forward.
In other news, today’s 126-point gain on the Dow is certainly very impressive. If things continue, the blue chip average looks to finish off a very strong week — proving good upside momentum for our plays on CAT, ABX, and CSX.Over on the put side, I like the fact that GRMN is up only fractionally today, which supports the underlying bearishness that’s taken hold of the stock.
Next week, we’ll start an exciting new week of trading. Until then…
Lock and load!
Sincerely,

© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.
Bottarelli Research alerts contain time-sensitive information, and are published and distributed to members with urgency. Because of this, not all published materials can be adequately proofread, and an occasional spelling or grammar error may exist.
Your Holiday-Shortened Update
DNA Moving on Approval
ATK Playing Defense
Setting Up Next Week
Take PEP Profits
Three “Bloated” Techs
Second Exit on PEP
Your Wednesday Update
Looking for Hammers
Shove Back
Three New Puts
Instant OIH Profits!
OIH Triggers at $9.10!
CDW Moving Lower
CDW Actually Beats
Dow Rallies 211 Points
MEDI’s Dreadful Quarter
Oil Services Remain Weak
CAT’s $1 Billion Profit
A Good Day to Be Long
Let’s Take Some Profits
End of Day Position Updates
Transports Get Jack-Hammered (again)
A Quick Downside Play
The Only Good Way for a Biotech to Spend Money
COF, Revisited
I Had this Cool Idea
The Incredible Difference in Post-Earnings Trading



